• Click Here to Close Popup

    Information on the Coronavirus

    New guidance for booster vaccinations In response to concerns about the new Omicron variant, the JCVI has recommended that booster vaccinations should be offered to all adults and that the gap between the second dose and booster is reduced to a minimum of 3 months.
    People who are severely immunosuppressed and have had their 3rd dose will also be offered a booster, a minimum of 3 months after their third dose.
    These recommendations will come into effect from 13 December. As before, people will be prioritised according to age and risk, and the NHS will contact you when it is your turn for your booster.
    Unfortunately we are not able to offer boosters to people under 40 due to the need to maintain other vital primary care services.
    However, there are a number of local vaccination services available which you will be able to choose from using the NHS National Booking Service.
    If you are aged 40 or over or in an at risk group and had your second dose 6 months ago, you can book your booster now at
    www.nhs.uk/covidvaccine or by calling 119.
    Otherwise, please wait to be contacted

    Accessibility Statement

Covid Information

Covid Vaccine Information

Oxford AstraZeneca Vaccine
New guidance has been issued for the use of the Oxford AstraZeneca Covid-19 vaccine.

This follows further reviews by the independent regulator, the MHRA, and the Commission for Human Medicines, of a very small number of people in the UK who have developed a rare blood-clotting condition since having the Oxford AstraZeneca Covid-19 vaccine.

The MHRA and Joint Committee for Vaccinations and Immunisations have emphasised that the risk of this condition is extremely small and that the benefits of the vaccine outweigh the risks for the vast majority of people. They have recommended that:

  • Everyone who has had the AstraZeneca vaccine should still have a second dose of the AstraZeneca vaccine, irrespective of age, unless they suffered any serious side effects after their first vaccination.
  • People aged 30 and over or who have a health condition that puts them at higher risk of severe Covid-19 disease should still be offered the Oxford AstraZeneca vaccine. The benefits in protecting them against the serious consequences of COVID-19 outweigh any risk of this rare condition.
  • People aged 18-29 who do not have a health condition that puts them at higher risk of severe Covid-19 disease will be offered an alternative Covid-19 vaccine where available. (This has been recommended as a precaution as people under 30 are at less risk from Covid-19 and not because they are considered to be at particular risk of developing the rare blood clot.)
  • People under 30 can still choose to have the Oxford AstraZeneca vaccine if this will mean they can be protected more quickly and they have been made aware of the guidance.

Please see the leaflet below that has been produced by Public Health England and the NHS to answer any questions you may have
Leaflet on COVID-19 vaccination and blood clotting

Comments are closed.